Association between dinucleotide repeat in non-coding region of interferon-gamma gene and susceptibility to, and severity of, rheumatoid arthritis

Lancet

Volumn 356, Issue 9232, 2000, Pages 820-825

  Khani Hanjani, A ^a   Lacaille, D ^a,b   Hoar, D ^a   Chalmers, A ^a,b   Horsman, D ^b   Anderson, M ^b   Balshaw, R ^c   Keown, P A ^a  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c SIMON FRASER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DINUCLEOTIDE; GAMMA INTERFERON;

ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DNA POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; NUCLEOTIDE REPEAT; PHYSICAL DISABILITY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

EID: 0034596490     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02657-X     Document Type: Article

References (35)

1. Prognostic factors in rheumatoid arthritis: Comparative study of two subsets of patients according to severity of articular damage
2. Emerging treatments for rheumatoid arthritis
3. The prognosis of rheumatoid arthritis: Assessment of disease activity and disease severity in the clinic
4. The genetic contribution to the pathogenesis of rheumatoid arthritis
5. Prognostic implications of HLA genotyping in the early assessment of patients with rheumatoid arthritis
6. Inherited and noninherited risk factors in rheumatoid arthritis
7. Tumor necrosis factor a microsatellite polymorphism is associated with rheumatoid arthritis severity through an interaction with the HLA-DRB1 shared epitope
8. Interleukin-1β, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms
9. Cellular responses to interferon-gamma
10. The molecular cell biology of interferon-γ and its receptor
11. Interferon-activated genes
12. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties
13. 245 heavy-chain gene expression and nicotinamideadenine dinucleotide phosphate hydrogenase oxidase in human leukemic myeloid cells
14. Orchestrated information transfer underlying leukocyte endothelial interactions
15. IFN-γ modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding
16. Role of cytokines in rheumatoid arthritis
17. Dinucleotide repeat polymorphism in the interferon-gamma (IFNG) gene
18. Association of polymorphism in the interferon γ gene with IDDM
19. In vitro production of IFN-γ correlates with CA repeat polymorphism in the human IFN-γ gene
20. Rapid DNA typing for class II HLA antigens: Subtyping of DRw52-associated DRB1 alleles
21. The molecular basis of rheumatoid arthritis
22. Recombinant human interferon gamma in the treatment of rheumatoid arthritis: Double blind placebo controlled study
23. New susceptibility locus for rheumatoid arthritis suggested by genome-wide linkage study
24. Linkage of cytokine genes to rheumatoid arthritis: Evidence of genetic heterogeneity
25. Increased frequency of the uncommon allele of a tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus
26. A tumor necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus
27. A Taq1 polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vitro
28. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on fibroblast-like synoviocytes: Paradoxical induction of IFN-gamma and TNF-alpha receptor expression
29. Analysis of an interferongamma gene (IFNG) polymorphism in Danish and Finnish insulin-dependent diabetes mellitus (IDDM) patients and control subjects. Danish Study Group of Diabetes in Childhood
30. Interferon-γ gene polymorphism-associated risk for multiple sclerosis in Sardinia
31. Interferon-γ gene microsatellite polymorphisms in patients with Graves' disease
32. Positive selection in autoimmunity: Abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis
33. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate
34. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with weekly methotrexate in rheumatoid arthritis